药学与临床研究
藥學與臨床研究
약학여림상연구
PHARMACEUTICAL AND CLINICAL RESEARCH
2014年
2期
180-182
,共3页
长江流域%药物利用%分析%用药金额%用药频度%MRSA
長江流域%藥物利用%分析%用藥金額%用藥頻度%MRSA
장강류역%약물이용%분석%용약금액%용약빈도%MRSA
Yangtze River valley%drug utilization%analysis%consumptions%DDDs MRSA
回顾分析2010~2012年长江流域抗MRSA药物应用状况及趋势。该类药物用药总金额逐年上升，其中糖肽类药物使用金额所占比重最大；通用名金额排序中万古霉素超越替考拉宁，位列第一；DDDs排序位于前列的有糖肽类和利奈唑胺。
迴顧分析2010~2012年長江流域抗MRSA藥物應用狀況及趨勢。該類藥物用藥總金額逐年上升，其中糖肽類藥物使用金額所佔比重最大；通用名金額排序中萬古黴素超越替攷拉寧，位列第一；DDDs排序位于前列的有糖肽類和利奈唑胺。
회고분석2010~2012년장강류역항MRSA약물응용상황급추세。해류약물용약총금액축년상승，기중당태류약물사용금액소점비중최대；통용명금액배서중만고매소초월체고랍저，위렬제일；DDDs배서위우전렬적유당태류화리내서알。
The utilization and development of anti-MRSA drugs in the Yangtze River valley were ret-rospectively analyzed. The consumption sum of anti-MRSA drugs in Yangtze River valley was increasing every year. Glycopeptides drugs were the most frequently used among them. The consumption sum of Van-comycinm exceeded that of Teicoplanin, topped in 2012. Glycopeptides drugs and Linezolid dominated in the rankings of DDDs.
